1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Role of targeted Immune therapies in relapsed refractory hodgkins lymphoma -A Multicentre experience from various transplant centres in Pakistan . A Lower middle income country perspective$

HL - 686

Role of targeted Immune therapies in relapsed refractory hodgkins lymphoma -A Multicentre experience from various transplant centres in Pakistan . A Lower middle income country perspective

Muhammad Sher Ali

Poster Presenter: Muhammad Sher Ali

Thumbnail for Role of Total Body Irradiation in Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implications for Clinical Practice

CT - 1186

Role of Total Body Irradiation in Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implications for Clinical Practice

Hegta Figueiroa

Poster Presenter: Hegta Figueiroa

SOHO 2026 Annual Meeting

Posters by Title

Role of targeted Immune therapies in relapsed refractory hodgkins lymphoma -A Multicentre experience from various transplant centres in Pakistan . A Lower middle income country perspective

Role of Total Body Irradiation in Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implications for Clinical Practice

Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Therapy, Exhibits a Manageable Safety Profile With Low Rates of Grade = 3 CRS and ICANS in Relapsed/Refractory Large B-Cell Lymphoma

Ropeginterferon Alfa-2b in Polycythemia Vera: A PRISMA-Compliant Systematic Review and Meta-Analysis

Ropeginterferon Alfa-2b vs Hydroxyurea in Polycythemia Vera: A Propensity Score-Matched Real-World Analysis of Thrombotic Events and Phlebotomy Burden

Rosai-Dorfman disease, histiocytosis, radiotherapy, rare diseases, real-world data

Rural-Urban Disparities in Leukemia Mortality Trends Among Young Adults Aged 15-34: A CDC Wonder Analysis (1999-2024)

Ruxolitinib Dose, Treatment-Emergent Transfusion Dependence, and Survival Outcomes in Myelofibrosis: Real-World Evidence From Taiwan

Ruxolitinib-Induced Complete Molecular Remission in Polycythemia Vera